本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

神经分泌生物科学

122.82
+1.801.49%
盘后122.820.00000.00%18:44 EDT
成交量:107.18万
成交额:1.31亿
市值:121.55亿
市盈率:41.53
高:123.07
开:120.19
低:120.19
收:121.02
数据加载中...
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities